Summary:
Long-Term Safety of ARQ-151 Cream in Adult Subjects With Chronic Plaque Psoriasis
Topical roflumilast cream for patients with Chronic Plaque Psoriasis involving up to 25% total Body Surface Area. Study medication will be applied by the qualifying subjects topically once daily for 52 weeks at home.
Criteria:- Males and females ages 18 years and older
- Subjects with chronic plaque psoriasis
- Psoriasis must involve over 25% of body
Qualified Participants May Receive:
- $800 in compensation for participating
- Free transportation reimbursement (Parking or Uber)
- Treatment at no cost at all